NCT06983444

Brief Summary

The aim of this study is to evaluate efficacy and safety of transurethral resection of the prostate and bipolar enucleation of the prostate.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jun 2025Jul 2026

First Submitted

Initial submission to the registry

April 29, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 21, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

1.1 years

First QC Date

April 29, 2025

Last Update Submit

May 17, 2025

Conditions

Keywords

TURPTUEPBPH

Outcome Measures

Primary Outcomes (1)

  • Catheter and lower urinary tract symptoms free after Bipolar Transurethral resection of prostate (TURP) versus Bipolar Transurethral enucleation of prostate (TUEP) in patient with BPH with lower urinary tract symptoms

    To determine number of patients in each group that will be Catheter and lower urinary tract symptoms free with changes in IPPS \< 20 score after intervention and follow up at 1 month, 3 months and 6 months.

    at least 6 months up to one year

Secondary Outcomes (7)

  • Operative time in minutes in each group of intervention

    60 - 90 minutes for each group of intervention

  • Compare complication rate of TURP versus TUEP

    at least 6 months up to one year

  • Cost effectiveness of TURP versus TUEP in achieving catheter-free rates in BPH patients with urinary retention

    at least 6 months up to one year

  • Compare patient reported symptom measures by IPSS questionnaire after TURP versus TUEP

    at least 6 months up to one year

  • Compare patient reported symptom measures by Michigan Incontinence Symptom Index (M-ISI) questionnaire after TURP versus TUEP

    at least 6 months up to one year

  • +2 more secondary outcomes

Study Arms (2)

Transurethral resection of prostate

ACTIVE COMPARATOR

Transurethral resection of prostate (TURP) will be performed under spinal or general anesthesia as per usual care.

Procedure: TURP

Transuretheral enucleation of prostate

ACTIVE COMPARATOR

Transurethral enucleation of prostate (TUEP) will be performed under spinal or general anesthesia as per usual care.

Procedure: TUEP

Interventions

TURPPROCEDURE

Using bipolar loop diathermy via cystoscopy, excess prostate tissue is resected piecemeal to remove obstruction to the prostatic urethra due to BPH.

Also known as: Transurethral resection of prostate, Bipolar TURP
Transurethral resection of prostate
TUEPPROCEDURE

Using bipolar enucleation loop diathermy via cystoscopy, to anatomically enucleate prostate.

Also known as: Transurethral enucleation of prostate, Bipolar TUEP, Anatomical endoscopic enucleation of prostate, AEEP
Transuretheral enucleation of prostate

Eligibility Criteria

Age50 Years - 80 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmale patient with BPH
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with lower urinary tract symptoms (LUTS) due to BPH.
  • Patients with international prostate score system (IPSS) more than 8.
  • Patients with maximal urinary flow rate (Qmax) less than 10ml/second.
  • Patients with Prostatic volume (60 - 100 gm).
  • Patient with indication for surgical intervention.
  • Patient age (50-80 years old)

You may not qualify if:

  • Prostatic cancer.
  • Bladder cancer.
  • Urethral stricture.
  • Neurogenic bladder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine South Valley University

Qina, Qena Governorate, 83523, Egypt

RECRUITING

Related Publications (6)

  • Zhang Y, Yuan P, Ma D, Gao X, Wei C, Liu Z, Li R, Wang S, Liu J, Liu X. Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. Prostate Cancer Prostatic Dis. 2019 Dec;22(4):493-508. doi: 10.1038/s41391-019-0135-4. Epub 2019 Feb 28.

    PMID: 30816336BACKGROUND
  • Seitz M, Sroka R, Gratzke C, Schlenker B, Steinbrecher V, Khoder W, Tilki D, Bachmann A, Stief C, Reich O. The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up. Eur Urol. 2007 Dec;52(6):1717-22. doi: 10.1016/j.eururo.2007.06.028. Epub 2007 Jun 26.

    PMID: 17628326BACKGROUND
  • Bachmann A, Schurch L, Ruszat R, Wyler SF, Seifert HH, Muller A, Lehmann K, Sulser T. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005 Dec;48(6):965-71; discussion 972. doi: 10.1016/j.eururo.2005.07.001. Epub 2005 Jul 18.

    PMID: 16126327BACKGROUND
  • Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012 Feb;109(3):408-11. doi: 10.1111/j.1464-410X.2011.10359.x. Epub 2011 Aug 23.

    PMID: 21883820BACKGROUND
  • Arcaniolo D, Manfredi C, Veccia A, Herrmann TRW, Lima E, Mirone V, Fusco F, Fiori C, Antonelli A, Rassweiler J, Liatsikos E, Porpiglia F, De Sio M, Autorino R; EAU Section of Uro-Technology (ESUT) Research Group. Bipolar endoscopic enucleation versus bipolar transurethral resection of the prostate: an ESUT systematic review and cumulative analysis. World J Urol. 2020 May;38(5):1177-1186. doi: 10.1007/s00345-019-02890-9. Epub 2019 Jul 25.

    PMID: 31346761BACKGROUND
  • Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW. A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol. 2007 Aug;52(2):517-22. doi: 10.1016/j.eururo.2007.03.038. Epub 2007 Mar 28.

    PMID: 17416453BACKGROUND

MeSH Terms

Conditions

Prostatic Hyperplasia

Interventions

Transurethral Resection of Prostate

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

ProstatectomyUrologic Surgical Procedures, MaleUrologic Surgical ProceduresUrogenital Surgical ProceduresSurgical Procedures, Operative

Central Study Contacts

AHMED A.FATAH HAMED, Master's

CONTACT

Mostafa A.Razik Ahmed, Doctorate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A comparison between TURP and Bipolar enucleation of prostate allows us to investigate the true benefits and safety of each modality.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

April 29, 2025

First Posted

May 21, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

May 21, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations